Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

OnabotulinumtoxinA Reduces Temporal Pain Processing at Spinal Level in Patients with Lower Limb Spasticity.

De Icco R, Perrotta A, Berra E, Allena M, Alfonsi E, Tamburin S, Serrao M, Sandrini G, Tassorelli C.

Toxins (Basel). 2019 Jun 20;11(6). pii: E359. doi: 10.3390/toxins11060359.

2.

The Effects of Transcutaneous Spinal Direct Current Stimulation on Neuropathic Pain in Multiple Sclerosis: Clinical and Neurophysiological Assessment.

Berra E, Bergamaschi R, De Icco R, Dagna C, Perrotta A, Rovaris M, Grasso MG, Anastasio MG, Pinardi G, Martello F, Tamburin S, Sandrini G, Tassorelli C.

Front Hum Neurosci. 2019 Feb 12;13:31. doi: 10.3389/fnhum.2019.00031. eCollection 2019.

3.

Body Weight Support Combined With Treadmill in the Rehabilitation of Parkinsonian Gait: A Review of Literature and New Data From a Controlled Study.

Berra E, De Icco R, Avenali M, Dagna C, Cristina S, Pacchetti C, Fresia M, Sandrini G, Tassorelli C.

Front Neurol. 2019 Feb 8;9:1066. doi: 10.3389/fneur.2018.01066. eCollection 2018.

4.

SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancer.

Zubiete-Franco I, García-Rodríguez JL, Lopitz-Otsoa F, Serrano-Macia M, Simon J, Fernández-Tussy P, Barbier-Torres L, Fernández-Ramos D, Gutiérrez-de-Juan V, López de Davalillo S, Carlevaris O, Beguiristain Gómez A, Villa E, Calvisi D, Martín C, Berra E, Aspichueta P, Beraza N, Varela-Rey M, Ávila M, Rodríguez MS, Mato JM, Díaz-Moreno I, Díaz-Quintana A, Delgado TC, Martínez-Chantar ML.

EBioMedicine. 2019 Feb;40:406-421. doi: 10.1016/j.ebiom.2018.12.031. Epub 2018 Dec 26.

5.

Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence.

Avataneo V, De Nicolò A, Rabbia F, Perlo E, Burrello J, Berra E, Pappaccogli M, Cusato J, D'Avolio A, Di Perri G, Veglio F.

Br J Clin Pharmacol. 2018 Nov;84(11):2535-2543. doi: 10.1111/bcp.13706. Epub 2018 Aug 15.

PMID:
29971815
6.

Impact of psychological profile on drug adherence and drug resistance in patients with apparently treatment-resistant hypertension.

Petit G, Berra E, Georges CMG, Capron A, Huang QF, Lopez-Sublet M, Rabbia F, Staessen JA, Wallemacq P, de Timary P, Persu A.

Blood Press. 2018 Dec;27(6):358-367. doi: 10.1080/08037051.2018.1476058. Epub 2018 Jun 28.

PMID:
29952236
7.

Effectiveness of Renal Denervation in Resistant Hypertension: A Meta-Analysis of 11 Controlled Studies.

Pappaccogli M, Covella M, Berra E, Fulcheri C, Di Monaco S, Perlo E, Burrello J, Monticone S, Rossato D, Rabbia F, Veglio F.

High Blood Press Cardiovasc Prev. 2018 Jun;25(2):167-176. doi: 10.1007/s40292-018-0260-5. Epub 2018 May 11.

PMID:
29752703
8.

Management of a Pregnant Woman With Fibromuscular Dysplasia.

Berra E, Dominiczak AF, Touyz RM, Pierard S, Hammer F, Rossi GP, Micali RG, Staessen JA, Bursztyn M, Kahan T, Persu A.

Hypertension. 2018 Apr;71(4):540-547. doi: 10.1161/HYPERTENSIONAHA.118.10819. Epub 2018 Feb 26. No abstract available.

PMID:
29483231
9.

Blood pressure response to renal denervation is correlated with baseline blood pressure variability: a patient-level meta-analysis.

Persu A, Gordin D, Jacobs L, Thijs L, Bots ML, Spiering W, Miroslawska A, Spaak J, Rosa J, de Jong MR, Berra E, Fadl Elmula FEM, Wuerzner G, Taylor AHM, Olszanecka A, Czarnecka D, Mark PB, Burnier M, Renkin J, Kjeldsen SE, Widimský J, Elvan A, Kahan T, Steigen TK, Blankestijn PJ, Tikkanen I, Staessen JA; European Network COordinating research on Renal Denervation (ENCOReD).

J Hypertens. 2018 Feb;36(2):221-229. doi: 10.1097/HJH.0000000000001582.

PMID:
29045339
10.

The hypoxia signalling pathway in haematological malignancies.

Irigoyen M, García-Ruiz JC, Berra E.

Oncotarget. 2017 May 30;8(22):36832-36844. doi: 10.18632/oncotarget.15981. Review.

11.

Procedural Reassessment of Radiofrequency Renal Denervation in Resistant Hypertensive Patients.

Rabbia F, Testa E, Fulcheri C, Berra E, Di Monaco S, Covella M, Pappaccogli M, Monticone S, Rosiello R, Rossato D, Veglio F.

High Blood Press Cardiovasc Prev. 2017 Jun;24(2):187-192. doi: 10.1007/s40292-017-0197-0. Epub 2017 Apr 3.

PMID:
28374154
12.

High prevalence of cardiac electric abnormalities in patients with phaeochromocytomas.

Berra E, Gonzalez MC, Scavée C, Vroonen L, Bersali A, Pouleur AC, Persu A.

J Hypertens. 2017 Apr;35(4):899-901. doi: 10.1097/HJH.0000000000001236. No abstract available.

PMID:
28248910
13.

Renal Artery Stenosis in Patients with Resistant Hypertension: Stent It or Not?

Van der Niepen P, Rossignol P, Lengelé JP, Berra E, Sarafidis P, Persu A.

Curr Hypertens Rep. 2017 Jan;19(1):5. doi: 10.1007/s11906-017-0703-8. Review.

PMID:
28150134
14.

Long-term oxytocin administration enhances the experience of attachment.

Bernaerts S, Prinsen J, Berra E, Bosmans G, Steyaert J, Alaerts K.

Psychoneuroendocrinology. 2017 Apr;78:1-9. doi: 10.1016/j.psyneuen.2017.01.010. Epub 2017 Jan 15.

PMID:
28131072
15.

Evaluation of a short home blood pressure measurement in an outpatient population of hypertensives.

Di Monaco S, Rabbia F, Covella M, Fulcheri C, Berra E, Pappaccogli M, Perlo E, Bertello C, Veglio F.

Clin Exp Hypertens. 2016;38(8):673-679. doi: 10.1080/10641963.2016.1200600. Epub 2016 Dec 9.

PMID:
27936339
16.

Assessing and treating pain associated with stroke, multiple sclerosis, cerebral palsy, spinal cord injury and spasticity. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation.

Paolucci S, Martinuzzi A, Scivoletto G, Smania N, Solaro C, Aprile I, Armando M, Bergamaschi R, Berra E, Berto G, Carraro E, Cella M, Gandolfi M, Masciullo M, Molinari M, Pagliano E, Pecchioli C, Roncari L, Torre M, Trabucco E, Vallies G, Zerbinati P, Tamburin S; Italian Consensus Conference on Pain in Neurorehabilitation (ICCPN).

Eur J Phys Rehabil Med. 2016 Dec;52(6):827-840. Epub 2016 Aug 31.

17.

Revisiting Fibromuscular Dysplasia: Rationale of the European Fibromuscular Dysplasia Initiative.

Persu A, Van der Niepen P, Touzé E, Gevaert S, Berra E, Mace P, Plouin PF, Jeunemaitre X; Working Group “Hypertension and the Kidney” of the European Society of Hypertension and the European Fibromuscular Dysplasia Initiative.

Hypertension. 2016 Oct;68(4):832-9. doi: 10.1161/HYPERTENSIONAHA.116.07543. Epub 2016 Aug 8. Review. No abstract available. Erratum in: Hypertension. 2016 Nov;68(5):e66.

PMID:
27504007
18.

Influence of oxytocin on emotion recognition from body language: A randomized placebo-controlled trial.

Bernaerts S, Berra E, Wenderoth N, Alaerts K.

Psychoneuroendocrinology. 2016 Oct;72:182-9. doi: 10.1016/j.psyneuen.2016.07.002. Epub 2016 Jul 5.

19.

Evaluation of Adherence Should Become an Integral Part of Assessment of Patients With Apparently Treatment-Resistant Hypertension.

Berra E, Azizi M, Capron A, Høieggen A, Rabbia F, Kjeldsen SE, Staessen JA, Wallemacq P, Persu A.

Hypertension. 2016 Aug;68(2):297-306. doi: 10.1161/HYPERTENSIONAHA.116.07464. Epub 2016 Jun 13. Review. No abstract available.

PMID:
27296995
20.

Alpha-1 antitrypsin deficiency: a novel cause of isolated systolic resistant hypertension?

Van Leeuw JB, Berra E, Gu Y, Petit T, Lacroix V, Lanthier N, Van Hoof M, Staessen JA, Persu A.

J Hypertens. 2016 Aug;34(8):1659-61. doi: 10.1097/HJH.0000000000000997. No abstract available.

PMID:
27270187
21.

DUBs, New Members in the Hypoxia Signaling clUb.

Schober AS, Berra E.

Front Oncol. 2016 Mar 9;6:53. doi: 10.3389/fonc.2016.00053. eCollection 2016. Review.

23.

Antihypertensive Bridge Therapy by Continuous Drug Infusion With an Elastomeric Pump in Device-Resistant Hypertension.

Rabbia F, D'Avolio A, Bernini G, Fulcheri C, De Nicolò A, Berra E, Bruno RM, Mulatero P, Taddei S, Veglio F.

Hypertension. 2016 Mar;67(3):e3-4. doi: 10.1161/HYPERTENSIONAHA.115.06978. Epub 2016 Jan 18. No abstract available.

PMID:
26781280
24.

Acute and Chronic Effect of Acoustic and Visual Cues on Gait Training in Parkinson's Disease: A Randomized, Controlled Study.

De Icco R, Tassorelli C, Berra E, Bolla M, Pacchetti C, Sandrini G.

Parkinsons Dis. 2015;2015:978590. doi: 10.1155/2015/978590. Epub 2015 Nov 26.

25.

Cellular Uptake and Cytotoxic Effect of Epidermal Growth Factor Receptor Targeted and Plitidepsin Loaded Co-Polymeric Polymersomes on Colorectal Cancer Cell Lines.

Goñi-de-Cerio F, Thevenot J, Oliveira H, Pérez-Andrés E, Berra E, Masa M, Suárez-Merino B, Lecommandoux S, Heredia P.

J Biomed Nanotechnol. 2015 Nov;11(11):2034-49.

PMID:
26554161
26.

Distinct breast cancer stem/progenitor cell populations require either HIF1α or loss of PHD3 to expand under hypoxic conditions.

Iriondo O, Rábano M, Domenici G, Carlevaris O, López-Ruiz JA, Zabalza I, Berra E, Vivanco Md.

Oncotarget. 2015 Oct 13;6(31):31721-39. doi: 10.18632/oncotarget.5564.

27.

Cost of Chronic and Episodic Migraine. A pilot study from a tertiary headache centre in northern Italy.

Berra E, Sances G, De Icco R, Avenali M, Berlangieri M, De Paoli I, Bolla M, Allena M, Ghiotto N, Guaschino E, Cristina S, Tassorelli C, Sandrini G, Nappi G.

J Headache Pain. 2015;16:532. doi: 10.1186/s10194-015-0532-6. Epub 2015 May 27.

28.

PHD3-SUMO conjugation represses HIF1 transcriptional activity independently of PHD3 catalytic activity.

Núñez-O'Mara A, Gerpe-Pita A, Pozo S, Carlevaris O, Urzelai B, Lopitz-Otsoa F, Rodríguez MS, Berra E.

J Cell Sci. 2015 Jan 1;128(1):40-9. doi: 10.1242/jcs.151514. Epub 2014 Nov 6.

29.

Hypoxia induces pluripotency in primordial germ cells by HIF1α stabilization and Oct4 deregulation.

López-Iglesias P, Alcaina Y, Tapia N, Sabour D, Arauzo-Bravo MJ, Sainz de la Maza D, Berra E, O'Mara AN, Nistal M, Ortega S, Donovan PJ, Schöler HR, De Miguel MP.

Antioxid Redox Signal. 2015 Jan 20;22(3):205-23. doi: 10.1089/ars.2014.5871. Epub 2014 Oct 30.

PMID:
25226357
30.

Renal sympathetic denervation in a previously stented renal artery.

Berra E, Rabbia F, Rossato D, Covella M, Totaro S, Chiara F, Di Monaco S, Veglio F.

J Clin Hypertens (Greenwich). 2014 Mar;16(3):238-9. doi: 10.1111/jch.12251. Epub 2014 Jan 4. No abstract available.

31.

Behavioral and neuroplastic effects of low-frequency rTMS of the unaffected hemisphere in a chronic stroke patient: a concomitant TMS and fMRI study.

Salatino A, Berra E, Troni W, Sacco K, Cauda F, D'Agata F, Geminiani G, Duca S, Dimanico U, Ricci R.

Neurocase. 2014;20(6):615-26. doi: 10.1080/13554794.2013.826691. Epub 2013 Aug 21.

PMID:
23962174
32.

Effectiveness of blood pressure educational and evaluation program for the improvement of measurement accuracy among nurses.

Rabbia F, Testa E, Rabbia S, Praticò S, Colasanto C, Montersino F, Berra E, Covella M, Fulcheri C, Di Monaco S, Buffolo F, Totaro S, Veglio F.

High Blood Press Cardiovasc Prev. 2013 Jun;20(2):77-80. doi: 10.1007/s40292-013-0012-5. Epub 2013 May 8.

PMID:
23653174
33.

Interaction between PARP-1 and HIF-2α in the hypoxic response.

Gonzalez-Flores A, Aguilar-Quesada R, Siles E, Pozo S, Rodríguez-Lara MI, López-Jiménez L, López-Rodríguez M, Peralta-Leal A, Villar D, Martín-Oliva D, del Peso L, Berra E, Oliver FJ.

Oncogene. 2014 Feb 13;33(7):891-8. doi: 10.1038/onc.2013.9. Epub 2013 Mar 4.

PMID:
23455322
34.

Deciphering the emerging role of SUMO conjugation in the hypoxia-signaling cascade.

Núñez-O'Mara A, Berra E.

Biol Chem. 2013 Apr;394(4):459-69. doi: 10.1515/hsz-2012-0319. Review.

PMID:
23362194
35.

Magnetic field triggered drug release from polymersomes for cancer therapeutics.

Oliveira H, Pérez-Andrés E, Thevenot J, Sandre O, Berra E, Lecommandoux S.

J Control Release. 2013 Aug 10;169(3):165-70. doi: 10.1016/j.jconrel.2013.01.013. Epub 2013 Jan 23.

PMID:
23353805
36.

Learning from Hypoxia Signaling: A working group meeting of the European COST action TD 0901, Bilbao, Spain, April 18 to 20, 2012.

Nunez-O'Mara A, Berra E.

High Alt Med Biol. 2012 Dec;13(4):291-2. doi: 10.1089/ham.2012.1066. No abstract available.

PMID:
23270449
37.

Appropriateness of referral to a European society of hypertension center of excellence.

Totaro S, Rabbia F, Testa E, Covella M, Berra E, Fulcheri C, Mulatero P, Veglio F.

J Clin Hypertens (Greenwich). 2012 Oct;14(10):729-30. doi: 10.1111/j.1751-7176.2012.00684.x. Epub 2012 Jul 9. No abstract available.

38.

Silent cerebrovascular damage and its early correlates in essential hypertensive patients.

Paglieri C, Rabbia F, Bergui M, Genesia ML, Canadè A, Berra E, Fulcheri C, Covella M, Di Stefano C, Cerrato P, Veglio F.

Clin Exp Hypertens. 2012;34(7):510-6. doi: 10.3109/10641963.2012.681720. Epub 2012 May 10.

PMID:
22574940
39.

Prolyl hydroxylase-dependent modulation of eukaryotic elongation factor 2 activity and protein translation under acute hypoxia.

Romero-Ruiz A, Bautista L, Navarro V, Heras-Garvín A, March-Díaz R, Castellano A, Gómez-Díaz R, Castro MJ, Berra E, López-Barneo J, Pascual A.

J Biol Chem. 2012 Mar 16;287(12):9651-8. doi: 10.1074/jbc.M111.299180. Epub 2012 Feb 3.

40.

Evaluation of blood pressure/height ratio as an index to simplify diagnostic criteria of hypertension in Caucasian adolescents.

Rabbia F, Rabbone I, Totaro S, Testa E, Covella M, Berra E, Bertello MC, Gioia E, Cerutti F, Veglio F.

J Hum Hypertens. 2011 Oct;25(10):623-4. doi: 10.1038/jhh.2011.32. Epub 2011 May 12. No abstract available.

PMID:
21562578
41.

A methodological reappraisal of non invasive high voltage electrical stimulation of lumbosacral nerve roots.

Troni W, Di Sapio A, Berra E, Duca S, Merola A, Sperli F, Bertolotto A.

Clin Neurophysiol. 2011 Oct;122(10):2071-80. doi: 10.1016/j.clinph.2011.03.002. Epub 2011 Mar 31.

PMID:
21458371
42.

Extended ischemia prevents HIF1alpha degradation at reoxygenation by impairing prolyl-hydroxylation: role of Krebs cycle metabolites.

Serra-Pérez A, Planas AM, Núñez-O'Mara A, Berra E, García-Villoria J, Ribes A, Santalucía T.

J Biol Chem. 2010 Jun 11;285(24):18217-24. doi: 10.1074/jbc.M110.101048. Epub 2010 Apr 5.

43.

HIF-1alpha mediates the induction of IL-8 and VEGF expression on infection with Afa/Dr diffusely adhering E. coli and promotes EMT-like behaviour.

Cane G, Ginouvès A, Marchetti S, Buscà R, Pouysségur J, Berra E, Hofman P, Vouret-Craviari V.

Cell Microbiol. 2010 May 1;12(5):640-53. doi: 10.1111/j.1462-5822.2009.01422.x. Epub 2009 Dec 21.

PMID:
20039880
44.

Inhibition of prolyl hydroxylase domain proteins promotes therapeutic revascularization.

Loinard C, Ginouvès A, Vilar J, Cochain C, Zouggari Y, Recalde A, Duriez M, Lévy BI, Pouysségur J, Berra E, Silvestre JS.

Circulation. 2009 Jul 7;120(1):50-9. doi: 10.1161/CIRCULATIONAHA.108.813303. Epub 2009 Jun 22.

PMID:
19546390
45.

HIF1 transcription factor regulates laminin-332 expression and keratinocyte migration.

Fitsialos G, Bourget I, Augier S, Ginouvès A, Rezzonico R, Odorisio T, Cianfarani F, Virolle T, Pouysségur J, Meneguzzi G, Berra E, Ponzio G, Buscà R.

J Cell Sci. 2008 Sep 15;121(Pt 18):2992-3001. doi: 10.1242/jcs.029256. Epub 2008 Aug 19.

46.

Effects of river pollution on the colonisation of artificial substrates by macrozoobenthos.

Bonzini S, Finizio A, Berra E, Forcella M, Parenti P, Vighi M.

Aquat Toxicol. 2008 Aug 11;89(1):1-10. doi: 10.1016/j.aquatox.2008.05.008. Epub 2008 May 18.

PMID:
18606467
47.

PHDs overactivation during chronic hypoxia "desensitizes" HIFalpha and protects cells from necrosis.

Ginouvès A, Ilc K, Macías N, Pouysségur J, Berra E.

Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4745-50. doi: 10.1073/pnas.0705680105. Epub 2008 Mar 17.

48.

Altered Stra13 and Dec2 circadian gene expression in hypoxic cells.

Guillaumond F, Lacoche S, Dulong S, Grechez-Cassiau A, Filipski E, Li XM, Lévi F, Berra E, Delaunay F, Teboul M.

Biochem Biophys Res Commun. 2008 May 16;369(4):1184-9. doi: 10.1016/j.bbrc.2008.03.009. Epub 2008 Mar 13.

PMID:
18342625
49.

The magic of the hypoxia-signaling cascade.

Benizri E, Ginouvès A, Berra E.

Cell Mol Life Sci. 2008 Apr;65(7-8):1133-49. doi: 10.1007/s00018-008-7472-0. Review.

PMID:
18202826
50.

The silencing approach of the hypoxia-signaling pathway.

Berra E, Pouysségur J.

Methods Enzymol. 2007;435:107-21. Review.

PMID:
17998051

Supplemental Content

Support Center